Related Experiment Videos
Pyrophosphorolysis-activated polymerization (PAP): application to allele-specific amplification
1City of Hope National Medical Center, Duarte, CA, USA.
Biotechniques
|November 21, 2000
Summary
Pyrophosphorolysis-activated polymerization (PAP) offers a novel method for highly specific allele amplification. This technique shows promise for detecting rare mutations or minimal residual disease with enhanced accuracy.
Area of Science:
- Molecular Biology
- Genetics
Background:
- Detecting rare mutations or minimal residual disease requires highly sensitive methods.
- Current allele-specific amplification techniques may lack the necessary specificity and robustness for ultra-sensitive detection.
Purpose of the Study:
- To introduce and validate pyrophosphorolysis-activated polymerization (PAP) as a novel allele-specific amplification method.
- To assess the potential of PAP for detecting one mutant allele among billions of wild-type alleles.
Main Methods:
- Developed PAP by coupling pyrophosphorolysis and polymerization using a pyrophosphorolysis-activatable oligonucleotide (P*).
- P* is an allele-specific oligonucleotide with a 3' dideoxynucleotide, activated by pyrophosphorolysis in the presence of pyrophosphate and a complementary template.
- Investigated the impact of various factors including dideoxyoligonucleotide sequences, DNA polymerases, PPi concentrations, and pH on PAP efficiency and specificity.
Main Results:
- Demonstrated proof of principle for PAP using a polymorphic site in the human D1 dopamine receptor gene.
- PAP achieves high specificity by requiring both correct pyrophosphorolysis and polymerization, making non-specific amplification extremely rare.
- Showcased the potential for robust amplification of specific alleles.
Conclusions:
- Pyrophosphorolysis-activated polymerization (PAP) presents a highly specific and robust method for allele-specific amplification.
- Further development, including engineering DNA polymerases with enhanced pyrophosphorolysis activity, could optimize PAP for ultra-sensitive mutation detection and minimal residual disease monitoring.